Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
| pediatric_iih [2024/01/04 15:28] – Scott Larson | pediatric_iih [2025/04/18 20:40] (current) – external edit 127.0.0.1 | ||
|---|---|---|---|
| Line 30: | Line 30: | ||
| ====Treatment==== | ====Treatment==== | ||
| - | ===[[Diamox|Acetazolamide]]=== | + | * [[diamox|]] |
| - | ===[[furosemide|Furosemide]]=== | + | |
| - | ===Andy Lee, MD=== | + | ===Andy Lee=== |
| * Starting dose: 25 mg/kg per day with a maximum dose of 100 mg/kg or 2 g per day. | * Starting dose: 25 mg/kg per day with a maximum dose of 100 mg/kg or 2 g per day. | ||
| * The sustained release formulation (Diamox sequels) may be better tolerated by patients who are intolerant of generic acetazolamide, | * The sustained release formulation (Diamox sequels) may be better tolerated by patients who are intolerant of generic acetazolamide, | ||
| Line 42: | Line 42: | ||
| ==== References ==== | ==== References ==== | ||
| - | * Lubaina M. Rangwala, MD, and Grant T. Liu, MD. Pediatric Idiopathic Intracranial Hypertension. [[http:// | + | * Lubaina M. Rangwala, MD, and Grant T. Liu, MD. Pediatric Idiopathic Intracranial Hypertension. [[http:// |
| - | * [[http:// | + | * [[http:// |
| - | * [[http:// | + | * [[http:// |
| {{tag> | {{tag> | ||